JamesWChuMD

Diabetes, Lipid Metabolism, Thyroid

Principal Investigator, Physician Owner

Dr. Chu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Monterey Endocrine & Diabetes Institute, Inc
2 Upper Ragsdale Drive, Suite B-200
Monterey, CA 93940
Phone+1 831-375-6334

Fax+1 831-375-6331

Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2002
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1996 - 1999
Stanford University School of MedicineClass of 1996
Harvard UniversityBA, Biology, Summa cum laude, 1987 - 1991

Timothy F Beckett Jr Award for Excellence in Clinical Teaching Stanford University School of Medicine, 2000
Lloyd W. Dinkelspiel Award for Distinctive Contributions to Undergraduate Education Stanford University, 1996
CMS Meaningful Use Stage 1 Certification Practice Partner EHR, McKesson Corporation, 2013
Fellow (FACE) American Association of Clinical Endocrinology
Join now to see all

PubMed

97 citations
Insulin resistance in idiopathic dilated cardiomyopathy: A possible etiologic link
Ronald M. Witteles, W.H. Wilson Tang, Aamer H. Jamali, James W. Chu, Gerald M. Reaven
Journal of the American College of Cardiology. 2004-07-07
696 citations
Use of metabolic markers to identify overweight individuals who are insulin resistant.
Tracey McLaughlin, Fahim Abbasi, Karen Cheal, James Chu, Cindy Lamendola
Annals of Internal Medicine. 2003-11-18
469 citations
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
Markus Stühlinger, Fahim Abbasi, James W. Chu, Cindy Lamendola, Tracey McLaughlin
JAMA. 2002-03-20